FDA Clears Spiriva Inhaler of Concerns About Stroke, MI
Sunday, January 31st, 2010Treatment with the Spiriva HandiHaler, which contains a dry powder formulation of the anticholinergic tiotropium, does not appear to be associated with an increased risk of stroke, myocardial infarction, or cardiovascular death in patients with chronic obstructive pulmonary disease, the Food and Drug Administration announced. (Source: Family Practice News)